Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis.
<h4>Objective</h4>To evaluate the efficacy and safety of IV laronidase for MPS I.<h4>Methods</h4>A systematic literature review was performed by searching the ClinicalTrials.gov, MEDLINE/PubMed, EMBASE, LILACS, and Cochrane Library databases, limited to clinical trials publis...
Saved in:
| Main Authors: | Alícia Dorneles Dornelles, Osvaldo Artigalás, André Anjos da Silva, Dora Lucia Vallejo Ardila, Taciane Alegra, Tiago Veiga Pereira, Filippo Pinto E Vairo, Ida Vanessa Doederlein Schwartz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0184065 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I
by: Ali Rabbani, et al.
Published: (2025-08-01) -
Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II
by: Alex J. Shamoun, et al.
Published: (2025-01-01) -
Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
by: Zhuomiao Lin, et al.
Published: (2025-08-01) -
MUCOPOLYSACCHARIDOSIS TYPE II
by: N.D. Vashakmadze, et al.
Published: (2011-06-01) -
Awareness of Mucopolysaccharidosis in an Otorhinolaryngologic Clinic
by: Hsiang-Yu Lin
Published: (2017-04-01)